SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-016563
Filing Date
2020-04-14
Accepted
2020-04-14 08:30:31
Documents
7
Period of Report
2020-05-27
Effectiveness Date
2020-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A evok-def14a_20200527.htm DEF 14A 840604
2 GRAPHIC gkavzvxjfwcq000003.jpg GRAPHIC 4489
3 GRAPHIC gkavzvxjfwcq000006.jpg GRAPHIC 57427
4 GRAPHIC gkavzvxjfwcq000005.jpg GRAPHIC 67053
5 GRAPHIC gkavzvxjfwcq000001.jpg GRAPHIC 4419
6 GRAPHIC gkavzvxjfwcq000002.jpg GRAPHIC 2530
7 GRAPHIC gkavzvxjfwcq000004.jpg GRAPHIC 2754
  Complete submission text file 0001564590-20-016563.txt   1033565
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 20790118
SIC: 2834 Pharmaceutical Preparations